Comments on Draft OIG Compliance Guidance

Dec 2 2002

For Pharmaceutical Manufacturers

Letter, Concerns with Trade-Related Aspects of Intellectual Property (TRIPS)

Nov 27 2002

Letter to The Honorable Robert Zoellick, US Trade Representative

BIO supports limited liability protection

Nov 18 2002
Letter to the Senate opposing an amendment to strike provisions in the Department of Homeland Security Act of 2002 that would provide limited liability protection for the production of antiterrorism countermeasures, vaccines, and therapeutics.

Court Decision Invalidating FDA's Pediatric Rule

Nov 14 2002


Bioterrorism: A Challenge We Cannot Decline to Meet

Nov 6 2002
Carl B. Feldbaum, BIO President (Nov. 6, 2002).

Letter on the PTO's strategic plan and their fee restructuring proposal

Oct 24 2002
We are writing to express our support for the efforts of the United States Patent and Trademark Office (USPTO) to address the crisis situation facing the patent and trademark systems.

FDA Letter Opposing Oregon Measure 27

Oct 4 2002
This letter explains why FDA objects to the pending ballot initiative to require the mandatory labeling of foods and food additives produced using genetic engineering sold in Oregon, or produced in Oregon and shipped to other states. In brief, FDA's scientific judgement is that there is no significant difference between foods produced using bioengineering, as a class, and their conventional counterparts.

FDA Letter Opposing Oregon Measure 27

Oct 4 2002

Sent to Governor Kitzhaber (October 4, 2002).

Letter Supporting HR 2215

Oct 2 2002
The Biotechnology Industry Organization (BIO) strongly supports the Conference Agreement on the Department of Justice Authorization Act (HR 2215) and urges passage by the U.S. Senate.

Letter Opposing H. Res. 517

Sep 20 2002
Letter from BIO to the U.S. House of Representatives strongly urging members not to sign the discharge petition (H. Res. 517) offered by the Democratic leadership that would bring the "Greater Access to Affordable Pharmaceuticals Act of 2001" (H.R. 1862/S.812) to the House floor for consideration.